
|Articles|August 15, 2003
Drug therapy may enhance outcomes of retinal repair
Fort Lauderdale, FL-Pharmacologic enhancement for retinal repair surgery continues to be a viable strategy, and the promise of its use to improve outcomes may be fulfilled as drug therapy enters a new era, said Mark S. Blumenkranz, MD, at the annual meeting of the Association for Research in Vision and Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Physician perspective: Glaucoma eye drops are here to stay
2
SparingVision completes PRODYGY trial patient dosing with SPVN06
3
American College of Physicians Calls for An End of the Term 'Provider' in Policy Paper
4
PRIMA System: A major step in the battle against GA
5




























